ClinicalTrials.govpublic full text
Minocycline In Neurocognitive Outcomes - Sickle Cell Disease
sickle cell disease, cognitive impairment, cognitive decline, cognitive change, cognitive dysfunction, cognitive deficit, neuroinflammatory response, benign hematology, neuroinflammation, interventional, phase1
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗Related documents
Record · ID 994358
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.